Products are for research use only, not for human use

Regulatory

Can You Buy Oxytocin in Canada? Prescription Status, the Acetate Salt, and How to Verify a Lot

Oxytocin is the one compound on a Canadian research shelf whose active ingredient is also a marketed Canadian drug. What is actually authorized here, how the acetate salt changes the arithmetic by 5.6%, and why the disulfide bridge is the stability liability.

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Written by Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

November 17, 202616 min read

Key Takeaways

  • •Oxytocin is a cyclic nonapeptide, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, closed by a disulfide bridge between cysteines 1 and 6, with CAS 50-56-6, formula C43H66N12O12S2 and an average mass of 1007.2 g/mol.
  • •The acetate is a salt of that same peptide, with its own CAS 6233-83-6, formula C45H70N12O14S2 and an average mass of 1067.2 g/mol.
  • •The salt form changes the arithmetic by about 5.6%. The peptide accounts for roughly 94.4% of the acetate salt's mass, so a certificate has to say which form was weighed.
  • •Oxytocin is prescription-only in Canada, and research-grade oxytocin acetate is not that product. The three marketed human products are hospital obstetric products from Pfizer, Fresenius Kabi and Hikma, and no other formulation and no over-the-counter product is authorized. The research material holds no DIN and is supplied for laboratory use only.
  • •ISMP Canada lists oxytocin as a high-alert medication in its use to start or advance labour.
  • •The disulfide bridge is the stability liability. Degradation of oxytocin in aqueous solution is well characterized and proceeds through routes a purity figure taken at release will not predict.

Summary

In Canada oxytocin is a prescription-only medicine: every oxytocin product in Health Canada's Drug Product Database carries a prescription schedule, the marketed human products are hospital obstetric products, and no other formulation is authorized. Research-grade oxytocin acetate is a different product, with no DIN and no authorization, supplied for laboratory work only. The acetate salt weighs about 6% more than the free peptide, so a certificate has to say which form its figures describe. The disulfide ring is the stability liability, and confirming it takes mass spectrometry rather than a purity figure.

Can you buy oxytocin in Canada? As a medicine, only on prescription and only as a hospital product: every oxytocin product in Health Canada's Drug Product Database is listed as prescription-only, the three human products currently marketed are all sterile solutions used in obstetric care, and no other oxytocin formulation is authorized here. That makes oxytocin acetate the one compound on a Canadian research shelf whose active ingredient is also a marketed Canadian drug, and the single case where the line between an authorized pharmaceutical and a research material cannot be hand-waved. Both exist, they are not the same product, and they are not even the same salt.

This guide covers what oxytocin is as a molecule, how the acetate differs from the free peptide, exactly what Health Canada has authorized and what it has not, how oxytocin compares with vasopressin and carbetocin, what the research literature measured, and why a nonapeptide with a disulfide bridge needs a different reading of a certificate. It is written for laboratory and in-vitro research procurement. It reports what published studies recorded because that is the public evidence base, and it contains no dosing, administration or human-use guidance, and none should be inferred.

What Oxytocin Is

Oxytocin is a neuropeptide hormone: it is synthesized by neurons of the hypothalamus, released from the posterior pituitary, and also acts as a chemical messenger within the brain.

Oxytocin was the first peptide hormone to be sequenced and synthesized, work for which Vincent du Vigneaud received the 1955 Nobel Prize in Chemistry. Its chemistry has been settled for seventy years, which makes it an unusually good reference point for reading a certificate.

PropertyValue (free peptide)Value (acetate salt)
SequenceCys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2same peptide
Ring closureDisulfide, Cys1 to Cys6same
Residues99
CAS number50-56-66233-83-6
Molecular formulaC43H66N12O12S2C45H70N12O14S2
Average mass1007.2 g/mol1067.2 g/mol
Monoisotopic mass1006.4365 Da1066.4576 Da

Those values agree with PubChem CID 439302 for the free peptide and CID 12004215 for the acetate.

A ball-and-stick model of a short peptide chain whose first and sixth units are joined by a bright orange bridge, closing a ring with a three-unit tail, illustrating the Cys1 to Cys6 disulfide bridge of oxytocin
A ball-and-stick model of a short peptide chain whose first and sixth units are joined by a bright orange bridge, closing a ring with a three-unit tail, illustrating the Cys1 to Cys6 disulfide bridge of oxytocin

The molecule has two structural features that matter downstream. It is cyclic, closed by a disulfide between the two cysteines, with a three-residue tail carrying a C-terminal amide. And it contains a glutamine at position 4 and an asparagine at position 5, both of which are amide side chains and both of which are the residues most prone to deamidation in aqueous solution.

The Salt Form Is Not a Labeling Detail

Peptides are supplied as salts, because the free peptide of a basic sequence is difficult to handle and the counterion is a consequence of the purification. "Oxytocin acetate" names the acetate salt of the oxytocin nonapeptide. The peptide inside is identical. What differs is the mass you weigh.

The arithmetic is worth doing once. The free peptide is 1007.2 g/mol and the acetate salt is 1067.2 g/mol, a difference of 60 g/mol, which is the mass of one acetate. So the peptide is about 94.4% of the acetate salt's mass, and 10 mg of the acetate salt contains roughly 9.4 mg of oxytocin peptide if the salt is stoichiometrically clean and dry.

That is the best case and it is rarely the actual case. A real lot also carries water, which a lyophilized peptide takes up readily, and may carry residual solvent or more than one counterion equivalent. The counterion arithmetic is the subject of chain length and counterion, and net peptide content is the measurement that settles it: it reports the fraction of the powder that is peptide, as measured, rather than as computed from an idealized salt.

It also explains an apparent discrepancy a careful buyer will notice across this market, including on Volta's own product page. Suppliers commonly name the product for the salt they ship while quoting the parent peptide's CAS number, formula and mass, because those are the identifiers the peptide is known by. Both numbers are true statements about different things. The useful question is which one the certificate's figures refer to, and a certificate that does not say has left a 5.6% ambiguity in the mass of material you think you bought.

Oxytocin vs Vasopressin and Carbetocin

Oxytocin has two close relatives that matter to anyone reading about it, and both are easy to confuse with it.

OxytocinVasopressin (arginine)Carbetocin
SequenceCys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2Oxytocin analogue with a modified N-terminus and a thioether in place of the disulfide
Ring closureDisulfide, Cys1 to Cys6Disulfide, Cys1 to Cys6Thioether (carba) bridge
Differences from oxytocinNonePositions 3 (Phe for Ile) and 8 (Arg for Leu)N-terminal and bridge modifications
Authorized in CanadaYes, prescription hospital productYes, prescriptionYes, prescription (Duratocin and a generic carbetocin)

Vasopressin differs from oxytocin at only two of nine positions, which is why the two hormones cross-react at each other's receptors at high concentrations. Carbetocin is a longer-acting synthetic analogue built to resist the degradation routes described below, and it is marketed in Canada as Duratocin by Ferring and as a generic carbetocin by Juno Pharma Canada.

Can You Buy Oxytocin in Canada?

This is the one table in this series with two columns that disagree, and the disagreement is the point.

QuestionAuthorized oxytocin productResearch-grade oxytocin acetate
Drug Identification NumberYes, multipleNone
Authorized as a medicine in CanadaYesNo
Currently marketed in CanadaYesNot applicable
Lawfully sold as a medicineYes, as an authorized productNo
Prescription requiredYes, every listed productNot a medicine
Authorized formSterile solution for hospital obstetric useNone
Any other formulation authorizedNoNo
Supplied asPrescription drugResearch material, in vitro use only

An active-ingredient search of the Health Canada Drug Product Database for oxytocin returns nineteen drug codes. Of those, several are recorded as currently marketed, including products from Pfizer Canada ULC (DIN 00497398), Fresenius Kabi Canada Ltd (DIN 02139561) and Hikma Canada Limited (DIN 02550199). The list also contains veterinary products, and a number of entries in dormant or cancelled states, which is normal for an ingredient with a long market history. Every one of the nineteen entries, human and veterinary, carries a prescription schedule, and every human product is a sterile solution for hospital use.

That answers the three questions Canadians most often ask about it. Oxytocin is not available over the counter. It cannot be bought legally without a prescription, because there is no non-prescription product. And the other oxytocin formulations advertised online are not authorized products in Canada: no such formulation appears in the database at all. ISMP Canada, the national medication-safety organisation, classifies oxytocin as a high-alert medication in its use to start or advance labour.

None of that authorization attaches to research-grade material. An authorized drug product is a specific formulation, made to a specific standard, in a specific presentation, by a named manufacturer, against a submission Health Canada reviewed. Research-grade oxytocin acetate is a lyophilized powder of the same peptide in a different salt form, with no marketing authorization, no DIN and no assessment of safety, efficacy or quality by any regulator. The shared active ingredient does not transfer the authorization, and the existence of an approved oxytocin product in Canada is not a statement about any research material.

That distinction is sharper here than anywhere else in this series, because for every other compound covered the answer is simply that nothing is authorized. The general framework for research material, and why a research-use label does not make a product lawful for human use, is in are peptides legal in Canada.

A sealed glass ampoule of clear solution beside a small vial of white lyophilised powder on a cream surface, illustrating that an authorized oxytocin product and a research-grade oxytocin acetate powder are different products despite sharing a peptide
A sealed glass ampoule of clear solution beside a small vial of white lyophilised powder on a cream surface, illustrating that an authorized oxytocin product and a research-grade oxytocin acetate powder are different products despite sharing a peptide

What the Published Research Measured

Oxytocin has an enormous literature spanning peripheral physiology and central nervous system work, and the two halves are often conflated in supplier copy.

The classical work concerns the peptide's actions on smooth muscle, which is the basis of the authorized clinical products. The newer and larger body of work concerns central effects, and its central methodological problem is delivery: the peptide crosses the blood-brain barrier poorly, so separating central from peripheral effects is difficult and the delivery method shapes what a study can conclude. Recent examples illustrate how carefully those studies are framed: a 2026 trial in Diabetes, Obesity and Metabolism reported that oxytocin did not affect glucose-regulating hormones or bone turnover markers during graded glucose infusion in healthy men (PMID 42687772), and a 2026 review in Translational Psychiatry examines the translational pathways of oxytocin in schizophrenia and the gap between neural mechanism and symptom domains (PMID 42236472).

The literature most useful to a buyer, though, is the stability work, because it is about the material rather than the biology:

  • A 2013 paper in Biopolymers addresses the mechanism of degradation of oxytocin and its analogues in aqueous solution (PMID 23868209).
  • A 2013 paper in the International Journal of Pharmaceutics reports that aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation (PMID 23376504).
  • Later work examines excipients and conjugation approaches intended to stabilize it, including crown ethers (PMID 33681619), sugars and glycols (PMID 34620274) and N-terminal PEGylation (PMID 27419537).

A compound with that many stabilization papers written about it is a compound that degrades readily in solution. That is the single most useful thing to know about handling it, and it is part of the reason carbetocin, with its more stable thioether bridge, was developed.

How to Verify an Oxytocin Acetate Lot

Establish which form the figures describe. Ask whether the reported mass and the net peptide content refer to the free peptide or the acetate salt. The gap is about 5.6% before water is counted, and it propagates into every concentration calculated from the vial.

Net peptide content is not optional here. Because the material is supplied as a salt and takes up water, the fraction of the powder that is peptide is the figure that determines what you actually weighed out. A purity ratio does not answer it.

Ask how the disulfide was confirmed. The molecule is cyclic, and the linear reduced form has the same amino acid composition and nearly the same mass, differing by about 2 Da for the two hydrogens. A mass spectrometric method with adequate resolution distinguishes them, as what actually proves a peptide sequence explains; a chromatographic purity figure may not, and the reduced form is a different molecule with different behavior. Dimerization through the disulfide is a known degradation route, and a dimer is a mass spectrometry finding rather than a purity finding. The Canadian checklist is in how to verify a peptide in Canada.

Treat release data as a release measurement. The stability literature above concerns aqueous solution, so a figure measured at release on a lyophilized powder does not describe the material after reconstitution. Storage conditions on the vial are load-bearing for this compound in a way they are not for a proline-rich linear peptide.

Check the three things that make a certificate checkable:

  1. The laboratory is named, with its report number.
  2. The lot number on the document matches the vial in your hand.
  3. The laboratory publishes a verification page where the report number can be looked up independently.

A certificate that names no laboratory, or whose lot number matches nothing on the container, is a document about some other material. Volta publishes its certificates as page images in its published certificate archive with the issuing laboratory's own verification link, and a certificate for the batch you receive is available on request. Those reports carry both HPLC and mass spectrometry results.

Frequently Asked Questions

What is oxytocin acetate?

It is the acetate salt of oxytocin, a cyclic nine-residue peptide with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 closed by a disulfide bridge between cysteines 1 and 6. The acetate salt has CAS 6233-83-6, formula C45H70N12O14S2 and an average mass of 1067.2 g/mol; the free peptide is CAS 50-56-6 at 1007.2 g/mol.

Can I buy oxytocin in Canada?

Only as a prescription medicine. Every oxytocin product in Health Canada's Drug Product Database is prescription-only, and the three marketed human products are hospital products from Pfizer, Fresenius Kabi and Hikma used in obstetric care. Research-grade oxytocin acetate is not a medicine and is supplied for laboratory use only.

Is oxytocin available over the counter in Canada?

No. There is no non-prescription oxytocin product in Canada; every listed product carries a prescription schedule.

Is any other oxytocin formulation authorized in Canada?

No. The Drug Product Database lists only hospital oxytocin products, so any other formulation sold online has no Canadian authorization.

What is the difference between oxytocin and carbetocin?

Carbetocin is a longer-acting synthetic analogue of oxytocin in which the disulfide bridge is replaced by a more stable thioether. It is a separately authorized prescription product in Canada, marketed as Duratocin and as a generic carbetocin.

Is oxytocin legal in Canada?

Oxytocin is an authorized prescription drug in Canada, with live Drug Identification Numbers from Pfizer, Fresenius Kabi and Hikma among others. Research-grade oxytocin acetate is a different product with no marketing authorization and no DIN, and is supplied for laboratory use only, a position set out in what that means in Canadian law. The authorization of the pharmaceutical product does not extend to research material.

Is research-grade oxytocin acetate the same as the authorized product?

No. The peptide is the same, but the salt form differs, and an authorized drug product is a specific formulation made to a specific standard by a named manufacturer against a reviewed submission. A lyophilized research powder is none of those things, whatever the active ingredient.

How much peptide is in 10 mg of the acetate salt?

Roughly 9.4 mg, if the salt is stoichiometrically clean and dry, because the peptide is about 94.4% of the acetate's formula mass. A real lot also carries water and possibly residual solvent, which is why net peptide content is measured rather than calculated.

Why does the disulfide bridge matter for verification?

The cyclic molecule and its reduced linear form share an amino acid composition and differ by about 2 Da, and dimerization through the disulfide is a known degradation route. Distinguishing these needs mass spectrometry with adequate resolution; a purity percentage may not separate them.

Does oxytocin degrade in solution?

Yes, readily, which is why the literature contains a substantial body of work on stabilizing it, including studies of buffers, divalent metal ions, crown ethers, sugars and PEGylation. A purity figure measured at release on a lyophilized powder does not describe the reconstituted material.

Sources

  • Health Canada Drug Product Database, active-ingredient search for oxytocin: nineteen drug codes, all on a prescription schedule, including currently marketed human products from Pfizer Canada ULC (DIN 00497398), Fresenius Kabi Canada Ltd (DIN 02139561) and Hikma Canada Limited (DIN 02550199); checked 10 November 2026.
  • Health Canada Drug Product Database, active-ingredient search for carbetocin: DURATOCIN (Ferring Inc., DIN 02496526) and a generic carbetocin (Juno Pharma Canada Inc., DIN 02489244), both marketed, prescription; checked 10 November 2026.
  • ISMP Canada. "Oxytocin to Start or Advance Labour: 5 Questions to Ask." Identifies oxytocin as a high-alert medication.
  • PubChem Compound Summary, CID 439302 (Oxytocin) and CID 12004215 (Oxytocin acetate). National Library of Medicine. Sequence, formulas, average masses and monoisotopic masses as cited above.
  • Biopolymers. 2013. "On the mechanism of degradation of oxytocin and its analogues in aqueous solution." PMID 23868209.
  • International Journal of Pharmaceutics. 2013. "Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation." PMID 23376504.
  • ACS Omega. 2021. "Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions." PMID 33681619.
  • Die Pharmazie. 2021. "The effect of D-(+)-glucosamine, N-acetyl-D-glucosamine and tetraethylene glycol on the stability of oxytocin in aqueous solution." PMID 34620274.
  • Biomacromolecules. 2016. "Stability Enhancing N-Terminal PEGylation of Oxytocin Exploiting Different Polymer Architectures and Conjugation Approaches." PMID 27419537.
  • Diabetes, Obesity and Metabolism. 2026. "Intravenous Oxytocin Does Not Affect Glucose-Regulating Hormones or Markers of Bone Turnover During Graded Glucose Infusion in Healthy Men." PMID 42687772.
  • Translational Psychiatry. 2026. "Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms." PMID 42236472.
Research Use Only. This article is provided for informational and educational purposes only. The compounds and topics discussed are intended solely for laboratory and scientific research. This content does not constitute medical advice, and Volta Peptides does not endorse or promote human consumption of any research compound.

About the author

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.

Marcus wrote this article, last reviewed November 10, 2026. It is in-house scientific writing by a named member of staff and is not peer review, independent third-party review or medical advice.

Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.